Old Web
English
Sign In
Acemap
>
authorDetail
>
William Slichenmyer
William Slichenmyer
Immunology
Tivozanib
Biology
Urology
QT interval
2
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract C123: A phase 1 study to evaluate the absorption, metabolism, and excretion of the vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI) tivozanib.
2011
Molecular Cancer Therapeutics
Monette M. Cotreau
Christine Hale
Lindsey Jacobson
Claudine S. Oelke
Andrew Strahs
Robert Kochan
William Slichenmyer
Dennis L. Vargo
Show All
Source
Cite
Save
Citations (3)
Abstract C121: A phase 1 QTc study of tivozanib in patients with advanced solid tumors.
2011
Molecular Cancer Therapeutics
Manpreet Chadha
Jeffrey R. Infante
Monette M. Cotreau
Lindsey Jacobson
Andrew Strahs
William Slichenmyer
Dennis L. Vargo
Kathleen N. Moore
Show All
Source
Cite
Save
Citations (0)
1